Prioritizing candidate drug targets for diseases with complex etiologies
My research has focused on the logic of gene expression regulation, particularly in response to stress. In particular, I have utilized and integrated high-dimensional data to address complex questions about regeneration, neurodegeneration, development, and evolution. My role in the Open-AD consortium is to integrate genomic evidence in support of the prioritization and development of new therapeutic targets for the treatment of Alzheimer's disease.
Carnegie Mellon University
Postdoctoral fellow
Adv: Dr. Veronica Hinman
2014-2020
University of Washington
Ph.D., Molecular and Cellular Biology
Adv: Aimee Dudley
2006-2013
Colby College
B.A., Biology
2000-2004
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.